Case number 3:24-cv-07346
ASTRAZENECA PHARMACEUTICALS LP et al v. CIPLA LIMITED et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 1, 2024 | N/A | CLERK'S QUALITY CONTROL MESSAGE - The 21 Letter submitted by Charles Chevalier on 10/31/2024 appear to be duplicates. These submissions will remain on the docket unless otherwise ordered by the court. This message is for informational purposes only. (kht) (Entered: 11/01/2024) (0) |
| Nov 1, 2024 | 22 | CONSENT DECREE and JUDGMENT of Non-Infringement Regarding U.S. Patent No. 8,475,842 filed. Signed by Judge Robert Kirsch on 11/1/2024. (mlh) (Entered: 11/04/2024) (5) |
| Nov 1, 2024 | 23 | STIPULATION AND ORDER of Dismissal of certain counts filed. Signed by Judge Robert Kirsch on 11/1/2024. (mlh) (Entered: 11/04/2024) (4) |
| Oct 31, 2024 | 20 | Letter from Charles H. Chevalier to the Honorable Robert Kirsch, U.S.D.J.. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 10/31/2024) (0) |
| Oct 31, 2024 | 21 | Letter from Charles H. Chevalier to the Honorable Robert Kirsch, U.S.D.J.. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 10/31/2024) (0) |
| Oct 8, 2024 | 19 | Letter from Charles H. Chevalier to the Honorable Tonianne J. Bongiovanni, U.S.M.J. re 16 Answer to Complaint,, Counterclaim,. (Attachments: # 1 Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 10/08/2024) (0) |
| Sep 20, 2024 | N/A | Clerk`s Text Order - The 18 Application for Clerk's Order to Ext Answer/Proposed Order submitted by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA UK LIMITED, ASTRAZENECA AB, MSD INTERNATIONAL BUSINESS GMBH, ASTRAZENECA PHARMACEUTICALS LP, THE UNIVERSITY OF SHEFFIELD has been GRANTED. The answer due date has been set for 10/8/2024. (amv) (Entered: 09/20/2024) (0) |
| Sep 19, 2024 | 18 | Application and Proposed Order for Clerk's Order to extend time to answer as to Defendants Cipla Limited and Cipla USA, Inc.'s counterclaims (ECF No. 16).. (CHEVALIER, CHARLES) (Entered: 09/19/2024) (3) |
| Sep 3, 2024 | 16 | ANSWER to Complaint , COUNTERCLAIM against ASTRAZENECA AB, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, KUDOS PHARMACEUTICALS LIMITED, MSD INTERNATIONAL BUSINESS GMBH, THE UNIVERSITY OF SHEFFIELD by CIPLA LIMITED, CIPLA USA, INC..(TOR, LOLY) (Entered: 09/03/2024) (30) |
| Sep 3, 2024 | 17 | Corporate Disclosure Statement by CIPLA LIMITED, CIPLA USA, INC. identifying InvaGen Pharmaceuticals, Inc., Cipla (EU Limited), and Cipla Limited as Corporate Parent.. (TOR, LOLY) (Entered: 09/03/2024) (2) |
| Aug 12, 2024 | 14 | PRETRIAL CONSOLIDATION ORDER Directing that all papers be filed and maintained in Civil Action No. 23-796. Signed by Magistrate Judge Tonianne J. Bongiovanni on 8/12/2024. (amv) (Entered: 08/13/2024) (7) |
| Aug 12, 2024 | 15 | STIPULATION AND CONSOLIDATED AMENDED PRETRIAL SCHEDULING ORDER. Signed by Magistrate Judge Tonianne J. Bongiovanni on 8/12/2024. (amv) (Entered: 08/13/2024) (8) |
| Aug 9, 2024 | 13 | Letter from Charles H. Chevalier, Esq. to the Honorable Tonianne J. Bongiovanni, U.S.M.J.. (Attachments: # 1 [Proposed] Amended Scheduling Order, # 2 [Proposed] Consolidation Order, # 3 [Proposed] Second Supplemental Stipulated Discovery Confidentiality Order)(CHEVALIER, CHARLES) (Entered: 08/09/2024) (0) |
| Aug 7, 2024 | N/A | Text Minute Entry for proceedings held before Magistrate Judge Tonianne J. Bongiovanni: Telephone Conference held on 8/7/2024. An update regarding status of discovery will be submitted by 12/11/2024. The cross use of Defendants' confidential information will be addressed when the parties advise that a resolution is necessary. (jem) (Entered: 08/09/2024) (0) |
| Jul 25, 2024 | 12 | TEXT ORDER: Oral Argument as to the dispute regarding the Discovery Confidentiality Order set for 8/7/2024 at 12:00 PM via via MS TEAMS before Magistrate Judge Tonianne J. Bongiovanni. The Court shall circulate the MS TEAMS link for the conference on a later date. So Ordered by Magistrate Judge Tonianne J. Bongiovanni on 7/25/2024. (jem) (Entered: 07/25/2024) (0) |
| Jul 3, 2024 | 10 | WAIVER OF SERVICE Returned Executed by MSD INTERNATIONAL BUSINESS GMBH, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, ASTRAZENECA PHARMACEUTICALS LP, KUDOS PHARMACEUTICALS LIMITED, THE UNIVERSITY OF SHEFFIELD. CIPLA LIMITED waiver sent on 7/3/2024, answer due 9/3/2024. (CHEVALIER, CHARLES) (Entered: 07/03/2024) (1) |
| Jul 3, 2024 | 11 | WAIVER OF SERVICE Returned Executed by MSD INTERNATIONAL BUSINESS GMBH, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, ASTRAZENECA PHARMACEUTICALS LP, KUDOS PHARMACEUTICALS LIMITED, THE UNIVERSITY OF SHEFFIELD. CIPLA USA, INC. waiver sent on 7/3/2024, answer due 9/3/2024. (CHEVALIER, CHARLES) (Entered: 07/03/2024) (1) |
| Jun 28, 2024 | 1 | COMPLAINT against CIPLA LIMITED, CIPLA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15480360) , Related Case Selected, filed by MSD INTERNATIONAL BUSINESS GMBH, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, ASTRAZENECA PHARMACEUTICALS LP, KUDOS PHARMACEUTICALS LIMITED, THE UNIVERSITY OF SHEFFIELD. (Attachments: # 1 Exhibit A ('562 patent), # 2 Exhibit B ('842 patent), # 3 Exhibit C ('396 patent), # 4 Exhibit D ('001 patent), # 5 Exhibit E ('530 patent), # 6 Certification Pursuant to Local Civil Rule 11.2, # 7 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 06/28/2024) (0) |
| Jun 28, 2024 | 2 | Corporate Disclosure Statement by ASTRAZENECA PHARMACEUTICALS LP identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 06/28/2024) (2) |
| Jun 28, 2024 | 3 | Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 06/28/2024) (2) |
| Jun 28, 2024 | 4 | Corporate Disclosure Statement by ASTRAZENECA AB identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 06/28/2024) (2) |
| Jun 28, 2024 | 5 | Corporate Disclosure Statement by THE UNIVERSITY OF SHEFFIELD. (CHEVALIER, CHARLES) (Entered: 06/28/2024) (2) |
| Jun 28, 2024 | 6 | Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 06/28/2024) (2) |
| Jun 28, 2024 | 7 | Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co., Inc. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 06/28/2024) (2) |
| Jun 28, 2024 | N/A | Judge Robert Kirsch and Magistrate Judge Tonianne J. Bongiovanni added. (jdg) (Entered: 06/28/2024) (0) |
| Jun 28, 2024 | 8 | SUMMONS ISSUED as to CIPLA LIMITED, CIPLA USA, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jdg) (Entered: 06/28/2024) (2) |
| Jun 28, 2024 | 9 | AO120 Patent/Trademark Form filed. (jdg) (Entered: 06/28/2024) (1) |
